SEARCH

SEARCH BY CITATION

References

  • 1
    National Institute for Heath and Care Excellence. Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection. London: NICE; 2012 [http://www.nice.org.uk/cg149].
  • 2
    Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M, iCAP Group (Improving Antibiotic Prescribing in Primary Care). Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011;96:F48.
  • 3
    Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011;96:F9F14.
  • 4
    National Institute for Heath and Care Excellence. Intrapartum Care: Management and Deliveryof Care to Women in Labour. London: NICE; 2007 [http://guidance.nice.org.uk/cg55].
  • 5
    National Institute for Heath and Care Excellence. Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: NICE; 2008 [http://www.nice.org.uk/cg62].
  • 6
    Royal College of Obstetricians and Gynaecologists. The Prevention of Early-Onset Neonatal Group B Streptococcal Disease. London: RCOG; 2012 [http://www.rcog.org.uk/files/rcog-corp/GTG36_GBS.pdf].
  • 7
    Health Protection Agency. Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2010. Health Protection Report, 2011;5:119 [http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131482001].
  • 8
    Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A. HPA GBS Working Group. Group B streptococcal disease in infants: a case control study. Arch Dis Child 2009;94:67480.
  • 9
    Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002;325:308.
  • 10
    Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG 2006;113:75865.
  • 11
    Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73:5837.
  • 12
    Morales WJ, Lim DV, Walsh AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986;155:97983.
  • 13
    Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:16659.
  • 14
    Mattoras R, Garcia-Perea A, Omenaca F, ez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991;40:5762.
  • 15
    National Collaborating Centre for Women's and Children's Health. Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection. London: RCOG; 2012 [http://guidance.nice.org.uk/CG149/Guidance/pdf/English].
  • 16
    Nadisauskiene R, Bergstrom S. Impact of intrapartum intravenous ampicillin on pregnancy outcome in women with preterm labor: a randomised, placebo-controlled study. Gynecol Obstet Invest 1996;41:858.
  • 17
    Nadisauskiene R, Bergstrom S, Kilda A. Ampicillin in the treatment of preterm labor: a randomised, placebo-controlled study. Gynecol Obstet Invest 1996;41:8992.
  • 18
    Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:131927.
  • 19
    Kenyon SL, Taylor DJ, Tarnow-Mordi W. ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357:97988.
  • 20
    Amon E, Lewis SV, Sibai BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988;159:53943.
  • 21
    Grable IA, Garcia PM, Perry D, Socol ML. Group B streptococcus and preterm premature rupture of membranes: a randomized, double-blind clinical trial of antepartum ampicillin. Am J Obstet Gynecol 1996;175:103642.
  • 22
    Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol 1989;73:7216.
  • 23
    Owen J, Groome LJ, Hauth JC. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Am J Obstet Gynecol 1993;169:97681.
  • 24
    Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol 72;8238.